US Patent 12084420 Indoline compounds for inhibiting KIF18A
Patent 12084420 was granted and assigned to Volastra Therapeutics on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+328 characters)
US Patent 12084420 Indoline compounds for inhibiting KIF18A
Article
Patent abstract
The present disclosure relates generally to inhibitors of KIF18A, compositions thereof, and methods of using the compounds and compositions thereof. More specifically, the present disclosure relates to indoline inhibitors of KIF18A and methods of their use for treating disease mediated by KIF18A, such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Derek A. Cogan0
Date of Patent
September 10, 2024
0Patent Application Number
178960370
Date Filed
August 25, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12084420 Indoline compounds for inhibiting KIF18A
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
